Current comorbidity among consecutive adolescent psychiatric outpatients with DSM-IV mood disorders

European Child & Adolescent Psychiatry
Linnea KarlssonM Marttunen

Abstract

To compare selected characteristics (age, sex, age of onset for depression, impairment, severity of depression, somatic comorbidity, and treatment status) of adolescents with currently comorbid and non-comorbid depression. A sample of 218 consecutive adolescent (13-19 years) psychiatric outpatients with depressive disorders, and 200 age- and sex-matched school-attending controls were interviewed for DSM-IV Axis I and Axis II diagnoses. Current comorbidity, most commonly with anxiety disorders, was equally frequent (>70%) in outpatients and depressed controls. Younger age (OR 0.20; 95% CI 0.08, 0.51) and male gender (OR 0.02; 95% CI 0.09, 0.55) were associated with concurrent disruptive disorders. Current comorbidity with substance use disorders (SUD) was independent of age (OR 1.13; 95% CI 0.51, 2.49) and sex (OR 0.51; 95% CI 0.22, 1.17). Personality disorders associated with older age (OR 2.06; 95% CI 1.10, 3.86). In multivariable logistic regression analysis, impairment (GAF <or=60) was associated with current comorbidity (OR 3.13; 95% CI 1.53, 6.45), while severity of depression and lifetime age of onset for depression were not. Adolescent depression presents with age- and sex-dependent patterns of multiple co-occurring prob...Continue Reading

References

May 1, 1991·Journal of Abnormal Psychology·P M LewinsohnH Hops
May 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·R HarringtonJ Hill
May 1, 1990·Archives of General Psychiatry·R HarringtonJ Hill
May 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·U RaoB Nelson
May 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·J BiedermanE Lelon
Jun 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·R M GiaconiaE Cohen
Aug 1, 1993·The American Journal of Psychiatry·D P BernsteinL Shinsato
Jul 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·E McCauleyR Treder
Dec 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·M SanfordD Jones
Sep 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·P M LewinsohnW H Sack
Feb 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·I M GoodyerJ Pearson
Jun 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·G J EmslieC W Hughes
Dec 24, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·P M LewinsohnD N Klein
Sep 15, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·D A BrentD Holder
May 18, 1999·JAMA : the Journal of the American Medical Association·M M WeissmanP Wickramaratne
Jul 27, 1999·Biological Psychiatry·J E AlpertJ F Rosenbaum
Oct 3, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·P WuM T Roper
Oct 13, 1999·The American Journal of Psychiatry·K N LevyT H McGlashan
Oct 13, 1999·The American Journal of Psychiatry·S KasenJ S Brook
Jan 13, 2000·Archives of General Psychiatry·B BirmaherR E Ulloa
Mar 14, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·M PelkonenJ Lönnqvist
Jun 30, 2001·Biological Psychiatry·J KaufmanD Charney
Jun 30, 2001·Biological Psychiatry·R C KesslerK Ries Merikangas
Feb 13, 2002·Journal of Child and Adolescent Psychopharmacology·S J Brooks, S Kutcher
Mar 7, 2002·Archives of General Psychiatry·Sara R JaffeeJudith Martin
Jun 7, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Kathleen Myers, Nancy C Winters
Jul 13, 2002·Journal of Affective Disorders·Terhi Aalto-SetäläJouko Lönnqvist
Sep 7, 2002·Psychological Medicine·M FavaJ J Worthington
Mar 21, 2003·Journal of Affective Disorders·Maria KovacsJoel Sherrill
May 3, 2003·The American Journal of Psychiatry·Drew WestenAndy Martens
Aug 13, 2003·Archives of General Psychiatry·E Jane CostelloAdrian Angold
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Dec 24, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Boris BirmaherNeal D Ryan

❮ Previous
Next ❯

Citations

Sep 10, 2008·European Child & Adolescent Psychiatry·I IsojokiR Kaltiala-Heino
Oct 19, 2013·Journal of Anxiety Disorders·Heidi J LynehamSarah E Carlson
Sep 26, 2013·Indian Journal of Pediatrics·Paul Swamidhas Sudhakar RussellSuma Nazeema
Mar 25, 2009·Journal of Adolescence·Virpi TuiskuMauri Marttunen
Apr 7, 2009·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Kate KeenanSusan Klostermann
Oct 20, 2006·Depression and Anxiety·Linnea KarlssonMauri Marttunen
Apr 19, 2011·Journal of Affective Disorders·Juha-Matti VäänänenRiittakerttu Kaltiala-Heino
Feb 20, 2016·The Journal of Nervous and Mental Disease·Thea StrandholmMauri Marttunen
Jan 25, 2014·Journal of Affective Disorders·Cecilia A EssauJohn R Seeley
Dec 7, 2016·The Journal of Nervous and Mental Disease·Thea StrandholmMauri Marttunen
May 22, 2020·International Review of Psychiatry·Koen Demyttenaere, Elke Heirman
Dec 12, 2018·Cognitive Behaviour Therapy·Alex KirkJ P Jameson
Sep 1, 2011·Irish Journal of Psychological Medicine·Carol FitzpatrickSuzanne Guerin
Oct 29, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Yuan GaoPing Wang
Dec 2, 2020·Drug and Alcohol Dependence·Joni LiskolaMauri Marttunen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.